| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/26/1994 | US5332676 Avipox virus promoter |
| 07/21/1994 | WO1994016060A1 Mutants of hiv for supression of hiv infection |
| 07/20/1994 | EP0606452A1 Vector vaccines of recombinant feline herpesvirus |
| 07/20/1994 | EP0606437A1 Non-shedding live herpesvirus vaccine |
| 07/20/1994 | EP0606376A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
| 07/12/1994 | US5328688 Recombinant herpes simplex viruses vaccines and methods |
| 07/07/1994 | WO1994014347A1 A protective garment |
| 07/07/1994 | WO1994005791A3 Dorsal tissue affecting factor and compositions |
| 07/07/1994 | WO1993022433A3 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
| 07/06/1994 | EP0605219A1 Products containing active milk protein components and process for producing the same |
| 07/06/1994 | EP0604566A1 Chimeric and/or growth-restricted flaviviruses |
| 06/29/1994 | EP0603615A2 Process of purification and enrichment of the Rubella Virus |
| 06/29/1994 | EP0603386A1 Parenteral immunization against rotavirus |
| 06/28/1994 | US5324655 Human Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusions |
| 06/28/1994 | CA1330426C Method for producing a heterologous protein in insect cells |
| 06/26/1994 | CA2111999A1 Products containing active milk proteins and process for producing the same |
| 06/23/1994 | WO1994013812A2 Novel entomopoxvirus genes, proteins and methods of use thereof |
| 06/23/1994 | WO1994013788A1 Recombinant viral vector system |
| 06/23/1994 | WO1994013700A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2151126A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2111998A1 Process for the purification and concentration of rubella virus |
| 06/22/1994 | EP0602761A1 Prevention and treatment of retroviral disease |
| 06/21/1994 | USRE34644 Hepatitis-A viruses adapted to human fibroblast cells |
| 06/21/1994 | US5322774 Procaryotic leader sequence in recombinant baculovirus expression system |
| 06/09/1994 | WO1994012615A1 Mycoplasma diagnostic assay |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/01/1994 | EP0598759A1 Recombinant infectious bovine rhinotracheitis virus |
| 05/31/1994 | US5316764 Immunization of dogs to form antibodies |
| 05/26/1994 | WO1994011025A1 Pathogenic porcine respiratory coronavirus |
| 05/26/1994 | WO1994010950A1 Microporous macrocapsules |
| 05/25/1994 | EP0598002A1 Viral vector-based insecticides and expression systems |
| 05/25/1994 | EP0597852A1 Swine pneumonia vaccine and method for the preparation thereof |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 05/18/1994 | EP0597008A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 05/17/1994 | CA1329562C Recombination resistant retroviral helper cell and products produced thereby |
| 05/11/1994 | WO1994010329A1 Rna packaging system |
| 05/11/1994 | WO1994010323A1 Virus with modified binding moiety specific for the target cells |
| 05/11/1994 | WO1994010322A1 Adenovirus-mediated ldl receptor gene transfer and targeting |
| 05/11/1994 | WO1994010321A1 Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine |
| 05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
| 05/11/1994 | EP0595970A1 Improved vaccine |
| 05/11/1994 | EP0595935A1 Papilloma virus vaccine |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | CA2147252A1 Rna packaging system |
| 05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
| 05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
| 05/10/1994 | US5310651 DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2 |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0594743A1 Continuous cell line and vaccine against avian coccidia |
| 05/04/1994 | CN1086143A Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 04/27/1994 | EP0593755A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 04/26/1994 | US5306614 Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2) |
| 04/26/1994 | US5306493 FeLV-infected feline cell line |
| 04/20/1994 | EP0593098A2 Process and device for selective removing of photodynamic substances from blood or bloodproducts |
| 04/20/1994 | EP0592636A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 04/20/1994 | EP0592546A1 Immunodeficiency virus recombinant poxvirus vaccine |
| 04/19/1994 | US5304466 HIV-3 retrovirus and its use |
| 04/19/1994 | US5304113 Method of eradicating infectious biological contaminants |
| 04/14/1994 | WO1994008026A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 04/14/1994 | WO1994008022A1 Vector to deliver and express foreign gene |
| 04/14/1994 | WO1994008000A1 Pseudorabies virus vaccine |
| 04/13/1994 | EP0591914A2 Retrovirus of the HIV-group and its application |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/13/1994 | EP0591382A1 De novo cell-free synthesis of picornavirus |
| 04/13/1994 | EP0591343A1 Method and apparatus for mass producing insects entomopathogens and entomoparasites |
| 04/13/1994 | EP0591281A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 04/13/1994 | EP0549721B1 Multiple promoter baculovirus expression system and defective particle production |
| 04/12/1994 | US5302702 Chimeric fibroblast growth factors |
| 04/06/1994 | EP0512011B1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 04/06/1994 | EP0432256B1 Improved biological insect control agents and methods of use |
| 04/05/1994 | US5300433 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 03/31/1994 | WO1994006921A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | WO1994006920A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
| 03/31/1994 | WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | WO1994006454A2 Inhibitiion of retrovirus infection |
| 03/31/1994 | WO1994006446A1 Hepatitis a virus vaccines |
| 03/31/1994 | WO1994003589A3 Hepatitis a virus vaccine |
| 03/31/1994 | CA2145063A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | CA2142325A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | CA2123584A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/29/1994 | US5298416 Attenuated polioviruses |
| 03/29/1994 | US5298413 Attenuated polioviruses |
| 03/29/1994 | US5298244 Proteins for immunology |
| 03/23/1994 | EP0587873A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
| 03/23/1994 | EP0587832A1 Method for testing blood units for viral contamination |
| 03/17/1994 | WO1994005792A1 Self-assembling recombinant papillomavirus capsid proteins |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005781A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 03/17/1994 | WO1994005327A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/16/1994 | EP0586438A1 Hepatitis a virus production |
| 03/15/1994 | US5294548 Baculovirus coding for the polyprotein in a infected host cell |